This month, the makers of the Type 2 diabetes drug, Actos, announced that they are adding the risk of bladder cancer onto Actos warning labels.
The announcement comes shortly after the Food and Drug Administration released the results of a large-scale study into the increased risk of bladder cancer for people taking Actos.
The FDA study examined more than 193,000 patients taking Actos for an average of 2 years. According to the study, Type 2 diabetes patients taking Actos for “longer than 12 months were associated with a 40 percent increase in risk [for bladder cancer].”
The FDA now advises doctors to not prescribe the drug to patients who have bladder cancer or who have had bladder cancer in the past.
If you or someone you love developed bladder cancer after taking Actos to treat Type 2 diabetes, contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810 to learn more about how we can help you.